Quick Answer
SpyGlass Pharma, Inc. reported Operating Income of -$41.45 million for fiscal year 2025.
SpyGlass Pharma, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$41.45M | -53.2% |
| 2024 | -$27.06M | — |
- SpyGlass Pharma, Inc. showed a decrease of -53.2% in Operating Income compared to the prior fiscal year.
- Over the 2024–2025 period, SpyGlass Pharma, Inc.’s operating income has declined by 53.2% (from -$27.06 million to -$41.45 million).
- The most recent figure is from SpyGlass Pharma, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: